Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: Distinct expression of cell-cycle- and differentiation-related genes

BMC Medical Genomics

Volumn 3, Issue , 2010, Pages

  Rodríguez Acebes, Sara ^a,b   Palacios, Nuria ^a   Botella Carretero, José I ^a,b   Olea, Nuria ^a   Crespo, Lorena ^a   Peromingo, Roberto ^a   Gámez Coronado, Diego ^a,b   Lasuncián, Miguel A ^a,b,c   Vzquez, Clotilde ^a,b   Martínez Botas, Javier ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; CCAAT ENHANCER BINDING PROTEIN BETA; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 2C; GLUCOSE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN JUN; PROTEIN P18; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ADULT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE CONVERSION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE PROBE; GENE SEQUENCE; GENETIC REGULATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GROWTH DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; MOLECULAR CLONING; MORBID OBESITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROADIPOCYTE; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SUBCUTANEOUS FAT; ADIPOSE TISSUE; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; MIDDLE AGED; MOUSE MUTANT;

ANIMALIA; MUS;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CELL CYCLE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; MICE, OBESE; MICROARRAY ANALYSIS; MIDDLE AGED; OBESITY, MORBID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 78650382390     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-3-61     Document Type: Article

References (70)

1. The continuing epidemics of obesity and diabetes in the United States. AH Mokdad BA Bowman ES Ford F Vinicor JS Marks JP Koplan, Jama 2001 286 10 1195 1200 10.1001/jama.286.10.1195 11559264
2. Adipose tissue as an endocrine organ. RS Ahima JS Flier, Trends Endocrinol Metab 2000 11 8 327 332 10.1016/S1043-2760(00)00301-5 10996528
3. The disease burden associated with overweight and obesity. A Must J Spadano EH Coakley AE Field G Colditz WH Dietz, Jama 1999 282 16 1523 1529 10.1001/jama.282.16.1523 10546691
4. Obesity as a medical problem. PG Kopelman, Nature 2000 404 6778 635 643 10766250
5. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. AG Renehan M Tyson M Egger RF Heller M Zwahlen, Lancet 2008 371 9612 569 578 10.1016/S0140-6736(08)60269-X 18280327
6. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. BH Goodpaster FL Thaete JA Simoneau DE Kelley, Diabetes 1997 46 10 1579 1585 10.2337/diabetes.46.10.1579 9313753
7. Relationships of generalized and regional adiposity to insulin sensitivity in men. N Abate A Garg RM Peshock J Stray-Gundersen SM Grundy, J Clin Invest 1995 96 1 88 98 10.1172/JCI118083 7615840
8. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. SR Smith JC Lovejoy F Greenway D Ryan L deJonge J de la Bretonne J Volafova GA Bray, Metabolism 2001 50 4 425 435 10.1053/meta.2001.21693 11288037
9. Adipose tissue cellularity in human obesity. J Hirsch B Batchelor, Clin Endocrinol Metab 1976 5 2 299 311 10.1016/S0300-595X(76)80023-0 1085232
10. Cytological and enzymological characterization of adult human adipocyte precursors in culture. RL Van CE Bayliss DA Roncari, J Clin Invest 1976 58 3 699 704 10.1172/JCI108516 956396
11. Adipocyte differentiation: from fibroblast to endocrine cell. FM Gregoire, Exp Biol Med (Maywood) 2001 226 11 997 1002 11743135
12. Transcriptional regulation of adipogenesis. ED Rosen CJ Walkey P Puigserver BM Spiegelman, Genes Dev 2000 14 11 1293 1307 10837022
13. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1. DE Phelps Y Xiong, Cell Growth Differ 1998 9 8 595 610 9716177
14. Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis. RF Morrison SR Farmer, J Biol Chem 1999 274 24 17088 17097 10.1074/jbc.274.24.17088 10358062
15. Modulation of early human preadipocyte differentiation by glucocorticoids. JJ Tomlinson A Boudreau D Wu E Atlas RJ Hache, Endocrinology 2006 147 11 5284 5293 10.1210/en.2006-0267 16873539
16. Relationship between replication and differentiation in cultured human adipocyte precursor cells. G Entenmann H Hauner, Am J Physiol 1996 270 4 Pt 1 1011 1016 8928727
17. Identifying regulatory hubs in obesity with nutrigenomics. DM Mutch, Current Opinion in Endocrinology, Diabetes and Obesity 2006 13 5 431 437 10.1097/01.med.0000244224.76033.06 (Pubitemid 44342168)
18. Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. K Linder P Arner A Flores-Morales P Tollet-Egnell G Norstedt, J Lipid Res 2004 45 1 148 154 10.1194/jlr.M300256-JLR200 14563828
19. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. M Corton JI Botella-Carretero A Benguria G Villuendas A Zaballos JL San Millan HF Escobar-Morreale B Peral, J Clin Endocrinol Metab 2007 92 1 328 337 10.1210/jc.2006-1665 17062763
20. Adipose gene expression prior to weight loss can differentiate and weakly predict dietary responders. DM Mutch MR Temanni C Henegar F Combes V Pelloux C Holst TI Sorensen A Astrup JA Martinez WH Saris,, et al. PLoS One 2007 2 12 1344 10.1371/journal.pone.0001344 18094752
21. Induction of the endoplasmic reticulum stress protein GADD153/CHOP by capsaicin in prostate PC-3 cells: a microarray study. AM Sanchez J Martinez-Botas S Malagarie-Cazenave N Olea D Vara MA Lasuncion I Diaz-Laviada, Biochem Biophys Res Commun 2008 372 4 785 791 10.1016/j.bbrc.2008.05.138 18533110
22. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. A Elbrecht Y Chen CA Cullinan N Hayes M Leibowitz DE Moller J Berger, Biochem Biophys Res Commun 1996 224 2 431 437 10.1006/bbrc.1996.1044 8702406
23. Adipose depot-specific effects of PPAR gamma agonists: a consequence of differential expression of PPAR gamma in adipose tissue depots? CT Montague, Diabetes Obes Metab 2002 4 6 356 361 10.1046/j.1463-1326.2002.00200.x 12406031
24. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. A Werman A Hollenberg G Solanes C Bjorbaek AJ Vidal-Puig JS Flier, J Biol Chem 1997 272 32 20230 20235 10.1074/jbc.272.32.20230 9242701
25. PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis. D Ren TN Collingwood EJ Rebar AP Wolffe HS Camp, Genes Dev 2002 16 1 27 32 10.1101/gad.953802 11782442
26. Mechanisms linking obesity with cardiovascular disease. LF Van Gaal IL Mertens CE De Block, Nature 2006 444 7121 875 880 10.1038/nature05487 17167476
27. C/EBPbeta regulates body composition, energy balance-related hormones and tumor growth. J Staiger MJ Lueben D Berrigan R Malik SN Perkins SD Hursting PF Johnson, Carcinogenesis 2009 30 5 832 840 10.1093/carcin/bgn273 19056928
28. CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. JM Schroeder-Gloeckler SM Rahman RC Janssen L Qiao J Shao M Roper SJ Fischer E Lowe DJ Orlicky JL McManaman,, et al. J Biol Chem 2007 282 21 15717 15729 10.1074/jbc.M701329200 17387171
29. Depot-related gene expression in human subcutaneous and omental adipocytes. CT Montague JB Prins L Sanders J Zhang CP Sewter J Digby CD Byrne S O'Rahilly, Diabetes 1998 47 9 1384 1391 10.2337/diabetes.47.9.1384 9726225
30. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. AJ Vidal-Puig RV Considine M Jimenez-Linan A Werman WJ Pories JF Caro JS Flier, J Clin Invest 1997 99 10 2416 2422 10.1172/JCI119424 9153284
31. Relationship between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha gene expression in obese human adipose tissue. A Redonnet S Bonilla C Noel-Suberville V Pallet H Dabadie H Gin P Higueret, Int J Obes Relat Metab Disord 2002 26 7 920 927 10.1038/sj.ijo.0802025 12080444
32. Adipose tissue distribution and quantification of PPARbeta/delta and PPARgamma1-3 mRNAs: discordant gene expression in subcutaneous, retroperitoneal and visceral adipose tissue of morbidly obese patients. JW Bortolotto R Margis AC Ferreira AV Padoin CC Mottin RM Guaragna, Obes Surg 2007 17 7 934 940 10.1007/s11695-007-9172-5 17894154
33. Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes. C Sewter F Blows R Considine A Vidal-Puig S O'Rahilly, J Clin Endocrinol Metab 2002 87 9 4203 4207 10.1210/jc.2002-011511 12213872
34. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. A Vidal-Puig M Jimenez-Linan BB Lowell A Hamann E Hu B Spiegelman JS Flier DE Moller, J Clin Invest 1996 97 11 2553 2561 10.1172/JCI118703 8647948
35. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor-gamma in human adipocytes. J Rieusset F Andreelli D Auboeuf M Roques P Vallier JP Riou J Auwerx M Laville H Vidal, Diabetes 1999 48 4 699 705 10.2337/diabetes.48.4.699 10102684
36. Effects of leptin on lipid metabolism and gene expression of differentiation-associated growth factors and transcription factors during differentiation and maturation of 3T3-L1 preadipocytes. WK Kim CY Lee MS Kang MH Kim YH Ryu KH Bae SJ Shin SC Lee Y Ko, Endocr J 2008 55 5 827 837 10.1507/endocrj.K08E-115 18497448
37. Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity. A Naaz DR Holsberger GA Iwamoto A Nelson H Kiyokawa PS Cooke, Faseb J 2004 18 15 1925 1927 15469964
38. Cyclin-dependent kinase inhibitor, p21WAF1/CIP1, is involved in adipocyte differentiation and hypertrophy, linking to obesity, and insulin resistance. N Inoue N Yahagi T Yamamoto M Ishikawa K Watanabe T Matsuzaka Y Nakagawa Y Takeuchi K Kobayashi A Takahashi,, et al. J Biol Chem 2008 283 30 21220 21229 10.1074/jbc.M801824200 18445590
39. Myeloid differentiation (MyD) primary response genes in hematopoiesis. DA Liebermann B Hoffman, Blood Cells Mol Dis 2003 31 2 213 228 10.1016/S1079-9796(03)00160-8 12972029
40. Adipocyte differentiation and gene expression. JM Ntambi K Young-Cheul, J Nutr 2000 130 12 3122S 3126S 11110885
41. Understanding adipocyte differentiation. FM Gregoire CM Smas HS Sul, Physiol Rev 1998 78 3 783 809 9674695
42. Differential expression of signal transducers and activators of transcription during human adipogenesis. JB Harp D Franklin AA Vanderpuije JM Gimble, Biochem Biophys Res Commun 2001 281 4 907 912 10.1006/bbrc.2001.4460 11237746
43. Dynamics of fat cell turnover in humans. KL Spalding E Arner PO Westermark S Bernard BA Buchholz O Bergmann L Blomqvist J Hoffstedt E Naslund T Britton,, et al. Nature 2008 453 7196 783 787 10.1038/nature06902 18454136
44. Adipocyte turnover: relevance to human adipose tissue morphology. E Arner PO Westermark KL Spalding T Britton M Ryden J Frisen S Bernard P Arner, Diabetes 2010 59 1 105 109 10.2337/db09-0942 19846802
45. Fat cell turnover in humans. P Arner KL Spalding, Biochem Biophys Res Commun 2010 396 1 101 104 10.1016/j.bbrc.2010.02.165 20494119
46. Stem cells and adipose tissue engineering. CT Gomillion KJ Burg, Biomaterials 2006 27 36 6052 6063 10.1016/j.biomaterials.2006.07.033 16973213
47. Obesity-induced inflammatory changes in adipose tissue. KE Wellen GS Hotamisligil, J Clin Invest 2003 112 12 1785 1788 14679172
48. Obesity is associated with macrophage accumulation in adipose tissue. SP Weisberg D McCann M Desai M Rosenbaum RL Leibel AW Ferrante Jr, J Clin Invest 2003 112 12 1796 1808 14679176
49. The role of angiopoietin-like proteins in angiogenesis and metabolism. T Hato M Tabata Y Oike, Trends Cardiovasc Med 2008 18 1 6 14 10.1016/j.tcm.2007. 10.003 18206803
50. Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. O Gealekman A Burkart M Chouinard SM Nicoloro J Straubhaar S Corvera, Am J Physiol Endocrinol Metab 2008 295 5 1056 1064 10.1152/ajpendo.90345.2008 18728224
51. Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation. JC Yoon TW Chickering ED Rosen B Dussault Y Qin A Soukas JM Friedman WE Holmes BM Spiegelman, Mol Cell Biol 2000 20 14 5343 5349 10.1128/MCB.20.14.5343-5349.2000 10866690
52. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. A Koster YB Chao M Mosior A Ford PA Gonzalez-DeWhitt JE Hale D Li Y Qiu CC Fraser DD Yang,, et al. Endocrinology 2005 146 11 4943 4950 10.1210/en.2005-0476 16081640
53. Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. H Ge G Yang X Yu T Pourbahrami C Li, J Lipid Res 2004 45 11 2071 2079 10.1194/jlr.M400138-JLR200 15292369 (Pubitemid 40990901)
54. Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. A Xu MC Lam KW Chan Y Wang J Zhang RL Hoo JY Xu B Chen WS Chow AW Tso,, et al. Proc Natl Acad Sci USA 2005 102 17 6086 6091 10.1073/pnas.0408452102 15837923
55. Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. U Desai EC Lee K Chung C Gao J Gay B Key G Hansen D Machajewski KA Platt AT Sands,, et al. Proc Natl Acad Sci USA 2007 104 28 11766 11771 10.1073/pnas.0705041104 17609370
56. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. RA Hegele CM Anderson J Wang DC Jones H Cao, Genome Res 2000 10 5 652 658 10.1101/gr.10.5.652 10810087
57. Common variation in LMNA increases susceptibility to type 2 diabetes and associates with elevated fasting glycemia and estimates of body fat and height in the general population: studies of 7,495 Danish whites. L Wegner G Andersen T Sparso N Grarup C Glumer K Borch-Johnsen T Jorgensen T Hansen O Pedersen, Diabetes 2007 56 3 694 698 10.2337/db06-0927 17327437
58. PCK1 and PCK2 as candidate diabetes and obesity genes. EG Beale BJ Harvey C Forest, Cell Biochem Biophys 2007 48 2-3 89 95 10.1007/s12013-007-0025-6 17709878
59. A possible physiological role for glyceroneogenesis in rat adipose tissue. L Reshef RW Hanson FJ Ballard, J Biol Chem 1970 245 22 5979 5984 5484457
60. Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. FJ Ballard RW Hanson GA Leveille, J Biol Chem 1967 242 11 2746 2750 6027245
61. Glucocorticoids control phosphoenolpyruvate carboxykinase gene expression in a tissue specific manner. H Nechushtan N Benvenisty R Brandeis L Reshef, Nucleic Acids Res 1987 15 16 6405 6417 10.1093/nar/15.16.6405 3627993
62. Expression of lipoprotein lipase in different human subcutaneous adipose tissue regions. P Arner H Lithell H Wahrenberg M Bronnegard, J Lipid Res 1991 32 3 423 429 2066672
63. Regulation of stearoyl-CoA desaturases and role in metabolism. JM Ntambi M Miyazaki, Prog Lipid Res 2004 43 2 91 104 10.1016/S0163-7827(03)00039-0 14654089
64. Mammalian long-chain acyl-CoA synthetases. E Soupene FA Kuypers, Exp Biol Med (Maywood) 2008 233 5 507 521 10.3181/0710-MR-287 18375835
65. Functional analysis of long-chain acyl-CoA synthetase 1 in 3T3-L1 adipocytes. S Lobo BM Wiczer DA Bernlohr, J Biol Chem 2009 284 27 18347 18356 10.1074/jbc.M109.017244 19429676
66. Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. DL Brasaemle G Dolios L Shapiro R Wang, J Biol Chem 2004 279 45 46835 46842 10.1074/jbc.M409340200 15337753
67. Regulation of sterol transport between membranes and NPC2. Z Xu W Farver S Kodukula J Storch, Biochemistry 2008 47 42 11134 11143 10.1021/bi801328u 18823126
68. Somatic cell plasticity and Niemann-pick type C2 protein: adipocyte differentiation and function. C Csepeggi M Jiang A Frolov, J Biol Chem 2010 285 39 30347 30354 10.1074/jbc.M110.135939 20650896
69. Next station in microarray data analysis: GEPAS. D Montaner J Tarraga J Huerta-Cepas J Burguet JM Vaquerizas L Conde P Minguez J Vera S Mukherjee J Valls,, et al. Nucleic Acids Res 2006 34 Web Server 486 491 10.1093/nar/gkl197 16845056
70. TM4: a free, open-source system for microarray data management and analysis. AI Saeed V Sharov J White J Li W Liang N Bhagabati J Braisted M Klapa T Currier M Thiagarajan,, et al. Biotechniques 2003 34 2 374 378 12613259